Innovation, Partnerships—for Lung Health and Veterans: Philips and 4DMedical
Industry leaders Jeff DiLullo, Executive Vice President and Chief Region Leader of Philips North America, and Prof. Andreas Fouras, Managing Director and Chief Executive Officer of 4DMedical, led a transformative session at the annual RSNA conference. The session discussed how the partnership between the two companies aims to enhance healthcare accessibility for Veterans; it highlighted collaborative efforts to improve cardiothoracic imaging and address the unique needs of Veterans, particularly those exposed to airborne toxins.
DoD to conduct Paid CT:VQ™ Pilot Ahead of FDA Submission
4DMedical has won a contract with the United States Department of Defense (DoD) to pilot its CT Ventilation-Perfusion (CT:VQ™) technology to assess lung health in a fixed cohort of active duty personnel.
This contract builds on the success of 4DMedical’s earlier agreement with the DoD for the deployment of its CT Lung Ventilation Analysis Software (CT LVAS™) in a clinical pilot program. The new arrangement reflects the DoD’s recognition of the utility and impact of 4DMedical’s technology in delivering critical health insights for active military personnel. The contracted arrangement with the DoD is best characterized as a commercial pilot, involving the delivery of a fixed number of scan analysis reports on full commercial terms.
4DMedical Receives U.S. FDA Clearance for IQ-UIP™
4DMedical has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ-UIP™ product, an advanced AI-driven lung diagnostic tool designed to revolutionize the diagnosis of Usual Interstitial Pneumonia (UIP), the hallmark radiological pattern for diagnosing Interstitial Pulmonary Fibrosis (IPF).